
    
      In hypertensive patients whose blood pressure (BP) does not reach less than 140/90 mmHg with
      5mg/day of amlodipine are divided the following two groups and BP response, laboratory data,
      and adverse effects are compared. Group 1: 12 week combination therapy with telmisartan plus
      low-dose hydrochlorothiazide. Group 2: Amlodipine is continuously administered.
    
  